Getting real-world evidence to the sponsor before the deadline, not after
Real‑world evidence only counts if it reaches the decision‑maker before the window closes.
When a non-interventional breast cancer study needed its interim analysis 10 days ahead of a tight plan, the TFS HealthScience oncology team did not add people or push back on the ask. They changed how the team worked.
In this case study you will discover:
- Why the solution had nothing to do with headcount
- How the team structure made the difference
- What the outcome looked like across every deliverable
Download the case study to see how the team delivered.
Connect with Us
Contact us today to discover how TFS can be your strategic CRO partner in clinical development.
Latest Oncology Resources

Insights from ASCO 2025: Oncology Clinical Trial Trends CROs and Sponsors Need to Know
Insights from ASCO 2025: Oncology Clinical Trial Trends CROs and Sponsors Need to Know

Rare Disease Day 2025: How Precision Medicine is Transforming Treatment for Rare Diseases
Rare Disease Day 2025: How Precision Medicine is Transforming Treatment for Rare Diseases

Revolutionizing Oncology Trials: The Power of Immunotherapy and Precision Medicine in Cancer Research
